Akums Drugs and Pharmaceuticals Limited IPO
Akums Drugs and Pharmaceuticals Limited was a mainboard IPO in the Pharmaceuticals sector, offered at ₹646–₹679 per share to raise ₹1,857 crore. The issue was subscribed 63.56× overall (QIBs 90.09×, NIIs 42.21×, retail 21.3×). It listed on 6 Aug 2024 at ₹725 and closed its first day at ₹796, a listing gain of +17.3% versus the ₹679 issue price. It now trades around ₹732 (+7.8% versus the issue price).
Frequently asked questions
- How many times was the Akums Drugs and Pharmaceuticals Limited IPO subscribed?
- The Akums Drugs and Pharmaceuticals Limited IPO was subscribed 63.56× overall — 90.09× in the QIB category, 42.21× among non-institutional investors, 21.3× in retail.
- What were the Akums Drugs and Pharmaceuticals Limited IPO listing gains?
- Akums Drugs and Pharmaceuticals Limited listed on 6 Aug 2024 at ₹725, closing its first day at ₹796 — a listing gain of +17.3% versus the ₹679 issue price.
- What were the retail allotment odds for the Akums Drugs and Pharmaceuticals Limited IPO?
- Retail was subscribed 21.3×, so a single-lot application had roughly a 4.7% chance of allotment (about 1 in 21), and allotment was finalised on 2 Aug 2024.
- What was the price band and lot size of the Akums Drugs and Pharmaceuticals Limited IPO?
- The price band was ₹646–₹679 per share, with a minimum lot of 22 shares (₹14,938 at the upper band).
- Who were the registrar and lead manager for the Akums Drugs and Pharmaceuticals Limited IPO?
- Link Intime India Private Limited was the registrar, and ICICI Securities was the book-running lead manager.